SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 101 filers reported holding SPERO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,875 | -21.3% | 8,988 | -5.7% | 0.00% | – |
| Q2 2023 | $13,819 | -37.4% | 9,530 | -37.4% | 0.00% | – |
| Q1 2023 | $22,084 | -25.2% | 15,230 | -10.8% | 0.00% | – |
| Q4 2022 | $29,543 | -22.3% | 17,077 | -11.3% | 0.00% | – |
| Q3 2022 | $38,000 | -73.6% | 19,254 | -90.1% | 0.00% | – |
| Q2 2022 | $144,000 | -77.3% | 194,431 | +166.4% | 0.00% | – |
| Q1 2022 | $635,000 | -21.4% | 72,996 | +44.6% | 0.00% | – |
| Q4 2021 | $808,000 | -22.4% | 50,485 | -10.6% | 0.00% | – |
| Q3 2021 | $1,041,000 | +6.9% | 56,501 | -19.0% | 0.00% | – |
| Q2 2021 | $974,000 | -65.0% | 69,772 | -63.1% | 0.00% | – |
| Q1 2021 | $2,781,000 | -47.1% | 188,949 | -30.3% | 0.00% | -100.0% |
| Q4 2020 | $5,259,000 | +1954.3% | 271,258 | +1082.9% | 0.00% | – |
| Q3 2020 | $256,000 | -26.4% | 22,932 | -11.0% | 0.00% | – |
| Q2 2020 | $348,000 | +3063.6% | 25,770 | +1746.0% | 0.00% | – |
| Q1 2020 | $11,000 | -93.1% | 1,396 | -91.6% | 0.00% | – |
| Q4 2019 | $159,000 | +253.3% | 16,554 | +293.3% | 0.00% | – |
| Q3 2019 | $45,000 | +164.7% | 4,209 | +182.1% | 0.00% | – |
| Q2 2019 | $17,000 | -58.5% | 1,492 | -53.5% | 0.00% | – |
| Q1 2019 | $41,000 | -75.0% | 3,207 | -88.0% | 0.00% | – |
| Q4 2018 | $164,000 | +11.6% | 26,799 | +91.1% | 0.00% | – |
| Q3 2018 | $147,000 | -31.3% | 14,024 | -3.9% | 0.00% | – |
| Q2 2018 | $214,000 | +36.3% | 14,594 | +32.3% | 0.00% | – |
| Q1 2018 | $157,000 | +26.6% | 11,030 | +4.5% | 0.00% | – |
| Q4 2017 | $124,000 | – | 10,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,353,303 | $1,637,497 | 13.93% |
| Anson Funds Management LP | 4,159,572 | $5,033,082 | 1.01% |
| OUP Management Co., LLC | 249,070 | $301,375 | 0.68% |
| Atlas Venture Life Science Advisors, LLC | 1,013,438 | $1,226,260 | 0.19% |
| Murchinson Ltd. | 862,700 | $1,043,867 | 0.13% |
| Alphabet Inc. | 889,979 | $1,076,874 | 0.07% |
| AWM Investment Company, Inc. | 333,400 | $403,414 | 0.06% |
| DAFNA Capital Management LLC | 125,000 | $151,250 | 0.05% |
| Novo Holdings A/S | 468,902 | $567,371 | 0.04% |
| XTX Topco Ltd | 58,368 | $70,625 | 0.01% |